Treatment & Services
- Abdominal Perineal Resection
- Anorectal Fistula Treatment
- Anorectal Surgery
- Clinical Trials
- Ileoanal Pouch
- J Pouch
- Laparoscopic Abdominal Perineal Resection
- Laparoscopic J-pouch Surgery
- Minimally Invasive Colorectal Surgery
- Pelvic Pouch Surgery for Ulcerative Colitis
- Rectal Cancer Surgery
- Re-Do Rectal Surgery
- Reoperative Abdominal Surgery
- Reoperative Pelvic Surgery
- Resection of Colon and Rectal Diseases
- Surgery For Crohn's Disease
- Surgery for Rectovaginal Fistula
Specialty in Diseases & Conditions
- Cancer of the Colon, Rectum and Anus
- Crohn's Disease
- Inflammatory Bowel Disease (IBD)
- Ulcerative Colitis
Is Cleveland Clinic Florida Part of Your Insurance?
Review a list of accepted insurance plans for our Florida locations or learn more about purchasing a contracted managed care plan.View All Plans
Education & Professional Highlights
Education & Fellowships
Fellowship - Mayo Clinic
Colon & Rectal Surgery
Rochester, MN USA
Residency - David Geffen School of Medicine @ UCLA
Los Angeles, CA USA
Medical Education - Boston University School of Medicine
Boston, MA USA
Undergraduate - Stanford University School of Medicine
Stanford, CA USA
- Postdoctoral fellowship in Stem Cell Biology at Stanford University
- Stem cell therapy for Crohn's disease
- Reconstructive pouch surgery
- General Surgery
- Colon and Rectal Surgery
inflammatory bowel disease, stem cell therapy, pouch reconstruction
Awards & Honors
ShermanPrize for Emerging Leader in Inflammatory Bowel Disease. Awardedto an emerging leader in inflammatory bowel disease with monetary support forresearch endeavors. 2018.
2018Transform the Practice Award, Translational work cost for “Theintra-arterial delivery of mesenchymal stem cells for the treatment of luminalCrohn’s disease: safety, efficacy, and its implications for disease discovery.”Primary Investigator, Mayo Clinic, Rochester MN, 2019-2021.
Centerfor Regenerative Medicine Research Award, “The local deliveryof mesenchymal stem cells for the treatment of fistulas related to Crohn’sdisease of the pouch” Primary Investigator, Mayo Clinic, RochesterMN, 2019-2021.
Centerfor Regenerative Medicine Research Award, “The local deliveryof mesenchymal stem cells for the treatment of rectovaginal fistulas related toCrohn’s disease” Primary Investigator, Mayo Clinic, RochesterMN, 2019-2021.
2018Department of Surgery Small Research Grant, Translational work costfor “MesenchymalStem Cells for Fistulizing Crohn’s Disease: Optimizing the CellularProduct for Future Investigation.”PrimaryInvestigator,Mayo Clinic, Rochester MN, 2018-2020.
2018Research Career Support and Advancement Award, Translationalwork cost for “The intra-arterial delivery of mesenchymal stem cells for thetreatment of luminal Crohn’s disease: safety, efficacy, and its implicationsfor disease discovery.”, Primary Investigator, Mayo Clinic, RochesterMN, 2018-2020.
AmericanSociety of Colon and Rectal Surgeons Career Development Award, Targeted, intra-arterial delivery ofmesenchymal stem cells for the treatment of luminal Crohn’s disease,Primary Investigator, Mayo Clinic, Rochester MN, 2018-2020.
Advancethe Practice Research Award, Imaging biomarkers derived from integrated Time-of-flight (TOF)FDG PET/MR Enterography for differentiating predominantly fibrotic frompredominantly inflammatory enteric strictures in patients with Crohn's disease,Co-Investigator, Mayo Clinic, Rochester MN, 2018-2020.
Center forRegenerative Medicine 2016 Career Development Regenerative Medicine Award, CareerDevelopment Award, Translational work cost for “Angiographic delivery of mesenchymal derivedstem cells for the treatment of severe medically refractory Ulcerative colitis(UC)”, Mayo Clinic, Rochester, MN, 2016-2018.
California Instituteof Regenerative Medicine (CIRM) Training Grant, Stem Cell Biology(TG2-01159), 2010-2012.
Training Grant, Molecularand Cellular Immunobiology (5 T32 AI07290), 2010-2011.
2018-present AssociateEditor, Diseases of the Colon and Rectum
2017-present AssociateEditor, Colorectal Disease
2017-present AssociateEditor, Inflammatory Bowel Disease
2017-present CCFAbstract Review Committee
2017-present CCFChair of Surgical Planning Committee
2017-present ASCRSPractice Guideline Writing Committee
2017-present ASCRSAssociate Chair of the Inflammatory Bowel Disease Committee
2015-present Member,European Crohn’s and Colitis Organization
2015-present Member,American Society of Colon and Rectal Surgeons
2015-present Member,Surgical Society of the Alimentary Tract
2015-present Member,Crohn’s and Colitis Foundation
Research & Publications
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 3/14/2019, Dr. Lightner has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.